|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs and debt discount | |||||
| Stock-based compensation | |||||
| Noncash interest expense and other charges | |||||
| Change in right of use asset | |||||
| Provision for excess and obsolete inventories | |||||
| Gain on extinguishment of debt | |||||
| Other non-cash charges | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued expenses and other current liabilities | |||||
| Other long-term liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the issuance of convertible preferred stock, net of commissions and issuance costs | |||||
| Common Stock | |||||
| Preferred Stock | |||||
| Total proceeds from the issuance of convertible preferred stock, net of commissions and issuance costs | |||||
| Proceeds from borrowings, net of issuance costs | |||||
| Proceeds from issuance of common stock under officers’ and directors’ purchase plan | |||||
| Net cash provided by financing activities | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Accretion of Series A preferred stock dividends | |||||
| Issuance of Series A preferred stock as dividend payment | |||||
| Reclassification of right of use asset to prepaid rent | |||||
| Transfers between inventory and property and equipment | |||||
| Purchases of property and equipment in accounts payable | |||||
| Conversion of CRG loan principal and accrued interest into Series E convertible preferred stock | |||||
Loading...